Pear Therapeutics, Inc. financial data

Location
200 State Street, 13 Th Floor, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Thimble Point Acquisition Corp. (to 12/3/2021)
Latest financial report
10-K - Q4 2022 - Mar 31, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 232 % -34.3%
Debt-to-equity 129 % +77.6%
Return On Equity -131 % -31.3%
Return On Assets -57 % -125%
Operating Margin -972 % +61.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 143M shares +3.56%
Common Stock, Shares, Outstanding 140M shares +1.9%
Entity Public Float 127M USD -53.5%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 139M shares +22.4%
Weighted Average Number of Shares Outstanding, Diluted 139M shares +22.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 12.7M USD +202%
Cost of Revenue 8.18M USD +56.4%
Research and Development Expense 48.3M USD +30.4%
Costs and Expenses 136M USD +23.8%
Operating Income (Loss) -123M USD -16.7%
Net Income (Loss) Attributable to Parent -75.5M USD -15.9%
Earnings Per Share, Basic -0.54 USD/shares +5.26%
Earnings Per Share, Diluted -0.54 USD/shares +5.26%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.3M USD -71.5%
Cash, Cash Equivalents, and Short-term Investments 59.3M USD -66%
Accounts Receivable, after Allowance for Credit Loss, Current 6.94M USD +287%
Assets, Current 73M USD -60.6%
Property, Plant and Equipment, Net 6.08M USD -2.86%
Operating Lease, Right-of-Use Asset 8.88M USD
Other Assets, Noncurrent 6.8M USD +29.5%
Assets 95.1M USD -51.8%
Accounts Payable, Current 3.26M USD +80.7%
Employee-related Liabilities, Current 10.1M USD -15%
Contract with Customer, Liability, Current 284K USD -32.5%
Liabilities, Current 49.4M USD +4.83%
Contract with Customer, Liability, Noncurrent 12K USD -45.5%
Operating Lease, Liability, Noncurrent 8.18M USD
Other Liabilities, Noncurrent 541K USD -72.9%
Liabilities 64.5M USD -39.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -47K USD -4600%
Retained Earnings (Accumulated Deficit) -323M USD -30.4%
Stockholders' Equity Attributable to Parent 30.6M USD -66.2%
Liabilities and Equity 95.1M USD -51.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.7M USD -75.1%
Net Cash Provided by (Used in) Financing Activities 75K USD -99.6%
Net Cash Provided by (Used in) Investing Activities -43.5M USD -20333%
Common Stock, Shares Authorized 690M shares 0%
Common Stock, Shares, Issued 140M shares +1.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -80.1M USD -18667%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.8M USD -71.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 900K USD 0%
Deferred Tax Assets, Valuation Allowance 99.8M USD +49.6%
Deferred Tax Assets, Gross 102M USD +51.9%
Operating Lease, Liability 10.2M USD
Depreciation 3.35M USD +98.2%
Payments to Acquire Property, Plant, and Equipment 501K USD -36.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75.5M USD -16%
Lessee, Operating Lease, Liability, to be Paid 13.4M USD
Property, Plant and Equipment, Gross 11.8M USD +36.7%
Operating Lease, Liability, Current 1.98M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.18M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 2.91M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.54M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.73M USD
Deferred Tax Assets, Operating Loss Carryforwards 73.9M USD +32%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.59M USD
Additional Paid in Capital 354M USD +4.64%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 155K USD +55%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 13.5M USD +255%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%